The overall valuation of the pelvic floor diagnostics market is projected to total USD 2,056.74 million in 2023. By the end of 2033, the market is estimated to equal USD 3,753.39 million, recording a CAGR of 6.2%.
The report also forecasts that the demand for uroflowmetry devices and anal manometry systems is expected to rise at 8.2% CAGR through the assessment period.
The growth of the pelvic floor diagnostics industry is primarily associated with the growing prevalence of pelvic floor disorders globally and rising healthcare expenditure. The developments of technologically advanced diagnostic systems and government support have led to a surge in demand for reliable and extensive diagnostic systems.
Improvements in reimbursement structures have led manufacturers to invest in the pelvic floor diagnostic sector creating a conducive environment for growth through 2033.
| Attributes | Details |
|---|---|
| Pelvic Floor Diagnostics Market Size (2023) | USD 2,056.74 million |
| Pelvic Floor Diagnostics Market Size (2033) | USD 3,753.39 million |
| Pelvic Floor Diagnostics Market CAGR (2023 to 2033) | 6.2% |
| Pelvic Floor Diagnostics Industry Size (2022) | USD 1,936.66 million |
Following Factors Set Forth Market Development:
Market Studded with Emerging Opportunities
Key Factors Instigating Obstacles in Market Development
Explore FMI!
Book a free demo
The pelvic floor diagnostics industry is expected to rise at a CAGR of 6.2% between 2023 and 2033 in comparison to the 3.5% CAGR registered from 2018 to 2022. This growth is highly associated with factors such as growing healthcare expenditure and rising technological advancements in the pelvic floor diagnostic sectors.
The prevalence of pelvic floor disorders, especially among pregnant women, and growing awareness for early diagnosis have further propelled sales of pelvic floor diagnostics systems. Growing research and development activities in the field have been supported by financial grants through key players and led to innovative disease control breakthroughs.
Rising awareness among women and men about early diagnosis has led to the increased setup of diagnostic imaging centers. There is a surge in demand for ultrasound imaging systems for high-resolution imaging over radiological methods.
The rise in healthcare spending and growing funding associated with favorable reimbursement has led manufacturers to invest in medical devices. This has resulted in increased adoption of pelvic floor diagnostics along with the growth of other related markets, such as treating pelvic floor prolapse and other dysfunctions.
The United States dominates the market for pelvic floor diagnostics and is expected to witness steady growth during the forecast period, according to Future Market Insights. The analysis estimates that the United States is expected to account for a market share of 81.5% in North America in 2023.
The growth of the pelvic floor diagnostics industry in the country is characterized by the rising prevalence rate of pelvic floor disorders among pregnant women and the subsequent rise in healthcare expenditure.
| Country | The United Kingdom |
|---|---|
| Forecast CAGR % (2023 to 2033) | 5.8% |
The United Kingdom pelvic floor diagnostics industry is expected to witness a CAGR of 5.8% over the forecast period. Government support and funding have promoted demand. The rapid increase in the geriatric population is a primary factor leading to an increase in pelvic floor disorders.
According to estimates conducted by the UNU (United Nations University), the percentage of geriatrics above 65 years of age is expected to rise to 16% by 2050 from 7% in 2000. A study conducted in 2005 by the World Health Organization determined that one of the significant factors leading to urinary incontinence in women is aging, which is also projected to support sales prospects.
| Country | Brazil |
|---|---|
| Forecast CAGR % (2023 to 2033) | 5.5% |
Brazil holds a current market share of more than 48.9% of the revenue generated in Latin America in 2023. According to the analysis by Future Market Insights, the country is expected to present highly lucrative growth with a CAGR of 5.5% over the forecast period.
Brazil is expected to support profitable growth due to the increasing prevalence of pelvic floor disorders such as overactive bladders and urinary incontinence among females. In Brazil, estimates of the prevalence of OAB range from 7.6% to 25%, and the rise in government regulations for its treatment.
The use of diagnostic devices and in-clinic diagnostic procedures for pelvic floor diagnosis has seen a proportionate increase along with the rising adoption rates by high-income population groups. The demand for hospitals and diagnostic laboratories for pelvic floor diagnosis has led to growth in the country.
In 2022, Mexico accounted for over 38.4% of the market share in Latin America. The moderately steady growth in the country is influenced by the growing demand for various pelvic floor diagnostic testing services.
Pelvic floor diagnosis has been hindered by the topic being considered taboo. Increasing expenditure and growing awareness programs by the government to support the population have led to a rise in the demand for pelvic floor diagnostics in Mexico.
| Segment | Ultrasound Systems |
|---|---|
| Forecast CAGR % (2023 to 2033) | 5.7% |
The demand for ultrasound systems in the pelvic floor diagnostics market globally is supported by the demand for ultrasound systems over radiological methods. Ultrasound systems amount to a substantial market share of 37.3% as of 2022 and are expected to grow over the forecast period at a CAGR of 5.7%.
The growing advancements in ultrasound systems have triggered a renewed interest in diagnostic imaging in urogynecology and female urology.
| Segment | Hospitals |
|---|---|
| Forecast CAGR % (2023 to 2033) | 5.5% |
Based on the end user, the hospital segment depicts a significant market share of 64.2% in 2023 and is projected to thrive at a CAGR of 5.5% over the forecast period.
The revenue growth of the hospital segment is projected to account for over USD 2,002.0 million by the end of the forecast period. The change is supported by improving health infrastructure, an increase in experienced physicians, the availability of advanced devices, and rising research and development spending for medical devices.
Key pelvic floor diagnostics market players are involved in innovative research and development activities for specialized and efficient diagnostic devices. Leading companies also focus on strategic mergers and acquisitions for geographical expansion and increased market footprint.
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | USD million for Value and Volume in ‘000’ Units |
| Key Regions Covered | North America; Latin America; Europe; East Asia; South Asia; Oceania; the Middle East and Africa |
| Key Countries Covered | The United States, Canada, Brazil, Mexico, the United Kingdom, Germany, France, Spain, Italy, Russia, India, Thailand, Indonesia, Malaysia, China, Japan, South Korea, Australia, Oceania, GCC Countries, South Africa, Türkiye |
| Key Segments Covered | Product, End User, and Region |
| Key Companies Profiled | LABORIE Inc.; CooperSurgical Inc.; SRS Medical; Medtronic Plc; MEDSPIRA; MEDKONSULT medical technology s.r.o.; Albyn Medical; PENTAX Medical; Olympus Medical Systems; Stryker's; EndoMed Systems; Richard Wolf; Schölly Fiberoptic; Zhuhai Seesheen Medical Technology; KARL STORZ; Cadwell; The Prometheus Group; Neurosoft; Noraxon USA |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The pelvic floor diagnostics industry is projected to reach a valuation of USD 3,753.39 million by 2033.
The Prometheus Group and Neurosoft are the top pelvic floor diagnostics industry players.
The United States is projected to hold a sizeable market share over the forecast period.
The pelvic floor diagnostics industry is projected to record a CAGR of 6.2%.
Hyperammonemia Treatment Market Trends – Growth & Therapeutic Advances 2025 to 2035
Home Respiratory Therapy Market – Growth & Forecast 2025 to 2035
Veterinary Auto-Immune Therapeutics Market Growth - Trends & Forecast 2025 to 2035
Radial Compression Devices Market Growth - Trends & Forecast 2025 to 2035
Digital Telepathology Market is segmented by Application and End User from 2025 to 2035
Suture Anchor Devices Market Is Segmented by Product Type, Material Type, Tying and End User from 2025 to 2035
Pelvic Floor Diagnostics Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
